NFKB1 and central nervous system cancer: (105) showed that WR1065 activated the NF-κB p50-p65 heterodimer, but not complexes with p62 or c-Rel, in SV40-immortalized human endothelial cells and glioma cell lines U87 (p53 competent) and U251 (p53 mutant).